Positive topline results presented for phase II study of Gazyva in lupus nephritis June 11, 2019 No Comments
Allena Pharmaceuticals presents interim results from Study 206 of reloxaliase June 5, 2019 No Comments
First patient enrolled in phase III FALCON trial of bardoxolone for the treatment of AKPKD May 31, 2019 No Comments
Phase III KALM-1 study of Korsuva in hemodialysis patients with pruritus meets primary endpoint May 30, 2019 No Comments
Gilead and Goldfinch Bio enter strategic collaboration to develop novel therapies for kidney disease May 10, 2019 No Comments
RSS